Figure 5.
Graphs showing the analysis of patients undergoing continuous follow-up to evaluate the progression of the pathology by evaluating the expression of microRNA-7-5p (fold-change, left scale, and orange line), expression of the BCR::ABL1 transcript (percentage, right scale, and blue line), treatment and treatment time, evaluating the date that is shown in Table 6. (A) Patient 1; (B) Patient 2; (C) Patient 3; (D) Patient 4; (E) Patient 5; and (F) Patient 6. BCR::ABL1: Percentage of BCR::ABL1 transcript in the sample; FC: Fold Change.